$213.23
7.423.61%
At close: Jun 8, 5:00 PM EST
$213.23
7.423.61%
Pre-Market: 4:09 AM EST
Ascendis Pharma AS Stock Guidance
ASNDNASDAQ
Ascendis Pharma (ASND) last issued guidance on January 9, 2026 for fiscal year 2025. The company guided revenue in the range of $838.19M - $838.19M for the period.
Latest Guidance Date
Jan 9, 2026
Guidance Period
Full Year 2025
Revenue Guidance Range
$838.19M - $838.19M
Ascendis Pharma Guidance History
Review all historical guidance issued by Ascendis Pharma, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for Ascendis Pharma (ASND)?
The most recent guidance for Ascendis Pharma (ASND) was reported on January 9, 2026 for the fiscal year 2025. Ascendis Pharma forecasted revenue between $838.19M and $838.19M for the period.
What revenue range did Ascendis Pharma (ASND) guide for?
Ascendis Pharma (ASND) guided revenue in the range of $838.19M to $838.19M for the fiscal year 2025.
When did Ascendis Pharma (ASND) last issue guidance?
Ascendis Pharma (ASND) last issued guidance on January 9, 2026 for the fiscal year 2025.
